Sotera Health (SHC)
(Delayed Data from NSDQ)
$11.40 USD
+0.08 (0.71%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $11.40 0.00 (0.00%) 6:30 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Sotera Health Company falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 51.38 | -233.57 | 117.12 | -37.49 | -20.43 |
Depreciation/Amortization & Depletion | 166.98 | 160.85 | 157.06 | 155.19 | 155.01 |
Net Change from Assets/Liabilities | -403.29 | 409.23 | -12.59 | -11.79 | -8.35 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 37.20 | -58.55 | 19.95 | 14.68 | 22.81 |
Net Cash From Operating Activities | -147.73 | 277.96 | 281.55 | 120.59 | 149.04 |
Property & Equipment | -214.98 | -182.38 | -102.16 | -53.51 | -57.26 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.07 | 0.48 | -57.67 | -105.19 | 0.00 |
Net Cash from Investing Activities | -214.91 | -181.90 | -159.83 | -158.69 | -57.26 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | -8.42 | 1,121.96 | 0.00 |
Issuance (Repayment) of Debt | 297.50 | 200.00 | -100.00 | -1,027.33 | 583.52 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | -691.17 |
Other Financing Activities | -31.54 | -2.24 | -8.87 | -21.20 | -18.38 |
Net Cash from Financing Activities | 265.96 | 197.76 | -117.29 | 73.43 | -126.03 |
Effect of Exchange Rate Changes | 2.04 | -4.46 | 0.04 | 4.11 | 0.49 |
Net Change In Cash & Equivalents | -94.64 | 289.37 | 4.47 | 39.43 | -33.76 |
Cash at Beginning of Period | 396.29 | 106.92 | 102.45 | 63.03 | 96.79 |
Cash at End of Period | 301.65 | 396.29 | 106.92 | 102.45 | 63.03 |
Diluted Net EPS | 0.18 | -0.83 | 0.41 | -0.16 | -0.09 |
Fiscal Year End for Sotera Health Company falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 51.38 | 12.70 | 26.36 | 2.84 |
Depreciation/Amortization & Depletion | NA | 166.98 | 123.73 | 83.14 | 41.45 |
Net Change from Assets/Liabilities | NA | -403.29 | -426.32 | -430.53 | -16.21 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 37.20 | 29.04 | 18.33 | 5.79 |
Net Cash From Operating Activities | NA | -147.73 | -260.86 | -302.70 | 33.87 |
Property & Equipment | NA | -214.98 | -150.15 | -98.13 | -45.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.07 | 0.07 | 0.03 | 0.03 |
Net Cash from Investing Activities | NA | -214.91 | -150.08 | -98.10 | -44.97 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 297.50 | 298.75 | 300.00 | 300.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -31.54 | -29.00 | -26.79 | -26.08 |
Net Cash from Financing Activities | NA | 265.96 | 269.75 | 273.21 | 273.92 |
Effect of Exchange Rate Changes | NA | 2.04 | -2.58 | 1.80 | 1.07 |
Net Change In Cash & Equivalents | NA | -94.64 | -143.76 | -125.80 | 263.89 |
Cash at Beginning of Period | NA | 396.29 | 396.29 | 396.29 | 396.29 |
Cash at End of Period | NA | 301.65 | 252.53 | 270.49 | 660.18 |
Diluted Net EPS | NA | 0.14 | -0.05 | 0.08 | 0.01 |